中国药物与临床
中國藥物與臨床
중국약물여림상
Chinese Remedies & Clinics
2015年
10期
1402-1404
,共3页
李敬%李颖%王荣霞%朱保月%刘晓婷%孔繁托%王岚
李敬%李穎%王榮霞%硃保月%劉曉婷%孔繁託%王嵐
리경%리영%왕영하%주보월%류효정%공번탁%왕람
一氧化碳中毒%缺血修饰白蛋白%治疗
一氧化碳中毒%缺血脩飾白蛋白%治療
일양화탄중독%결혈수식백단백%치료
Carbon monoxide poisoning%Ischemia modified albumin%Therapy
目的:探讨舒血宁联合磷酸肌酸钠对急性一氧化碳中毒(ACOP)患者缺血修饰白蛋白(IMA)水平的影响及临床疗效比较。方法选择ACOP患者86例随机分为常规组及治疗组,所有入选者治疗前,治疗后6 h、3 d分别抽取静脉血检测肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)、肌钙蛋白I(cTnI)、IMA水平。结果治疗前IMA均显著降低,而CK、CK-MB、cTnI无明显改变。治疗后6 h,治疗组IMA升高较常规组明显,差异有统计学意义(P<0.05)。CK、CK-MB、cTnI逐渐升高,2组比较差异无统计学意义(P>0.05)。治疗后3 d,常规组cTnI水平较治疗组升高明显,2组比较差异有统计学意义(P<0.05)。常规组与治疗组比较,CK、CK-MB、IMA均恢复正常水平,2组比较差异无统计学意义(P>0.05)。治疗后3 d cTnI水平与治疗后6 h水平比较明显好转,差异有统计学意义(P<0.05)。结论 ACOP患者早期给予舒血宁联合磷酸肌酸钠治疗,IMA水平明显升高,中毒性心肌损伤明显恢复。IMA水平可作为心肌缺血及药物治疗的评价指标。
目的:探討舒血寧聯閤燐痠肌痠鈉對急性一氧化碳中毒(ACOP)患者缺血脩飾白蛋白(IMA)水平的影響及臨床療效比較。方法選擇ACOP患者86例隨機分為常規組及治療組,所有入選者治療前,治療後6 h、3 d分彆抽取靜脈血檢測肌痠激酶(CK)、肌痠激酶同工酶(CK-MB)、肌鈣蛋白I(cTnI)、IMA水平。結果治療前IMA均顯著降低,而CK、CK-MB、cTnI無明顯改變。治療後6 h,治療組IMA升高較常規組明顯,差異有統計學意義(P<0.05)。CK、CK-MB、cTnI逐漸升高,2組比較差異無統計學意義(P>0.05)。治療後3 d,常規組cTnI水平較治療組升高明顯,2組比較差異有統計學意義(P<0.05)。常規組與治療組比較,CK、CK-MB、IMA均恢複正常水平,2組比較差異無統計學意義(P>0.05)。治療後3 d cTnI水平與治療後6 h水平比較明顯好轉,差異有統計學意義(P<0.05)。結論 ACOP患者早期給予舒血寧聯閤燐痠肌痠鈉治療,IMA水平明顯升高,中毒性心肌損傷明顯恢複。IMA水平可作為心肌缺血及藥物治療的評價指標。
목적:탐토서혈저연합린산기산납대급성일양화탄중독(ACOP)환자결혈수식백단백(IMA)수평적영향급림상료효비교。방법선택ACOP환자86례수궤분위상규조급치료조,소유입선자치료전,치료후6 h、3 d분별추취정맥혈검측기산격매(CK)、기산격매동공매(CK-MB)、기개단백I(cTnI)、IMA수평。결과치료전IMA균현저강저,이CK、CK-MB、cTnI무명현개변。치료후6 h,치료조IMA승고교상규조명현,차이유통계학의의(P<0.05)。CK、CK-MB、cTnI축점승고,2조비교차이무통계학의의(P>0.05)。치료후3 d,상규조cTnI수평교치료조승고명현,2조비교차이유통계학의의(P<0.05)。상규조여치료조비교,CK、CK-MB、IMA균회복정상수평,2조비교차이무통계학의의(P>0.05)。치료후3 d cTnI수평여치료후6 h수평비교명현호전,차이유통계학의의(P<0.05)。결론 ACOP환자조기급여서혈저연합린산기산납치료,IMA수평명현승고,중독성심기손상명현회복。IMA수평가작위심기결혈급약물치료적평개지표。
Objective To investigate the effect of Ginkgo Biloba leaf extract and creatine phosphate sodium on ischemia modified albumin (IMA) level in patients with acute carbon monoxide poisoning (ACOP), and to compare the clinical efficacy before and after the treatment. Methods Eighty-six patients with ACOP were included as the sub-jects in the study, and were randomly divided into the conventional group and the treatment group. The CK, CK-MB, cTnI, and IMA levels in venous blood of all subjects were determined at 6 h and 3 d before and after the treatment, respectively. Results IMA was significantly decreased before the treatment, whereas no significant changes were found on CK, CK-MB and cTnI levels. At 6 h after the treatment, IMA was significantly increased in the treatment group compared with that in the conventional group, with statistically significant difference ( P<0.05);whereas CK, CK-MB and cTnI levels increased gradually, without differences between the conventional group and the treatment group (P>0.05). At 3 d after the treatment, cTnI level was significantly increased in the conventional group compared with that in the treatment group, with significant difference between the two groups ( P<0.05). CK, CK-MB and IMA levels all returned to normal and there were no differences between the conventional group and the treatment group ( P>0.05). The cTnI level was significantly improved at 3 d after the treatment compared with that at 6 h after the treatment ( P<0.05). Conclusion IMA level is significantly increased and poisoning induced myocardial injury is significantly re covered in ACOP patients received early treatment with Ginkgo Biloba leaf extract and creatine phosphate sodium. IMA level can be used as evaluation index of myocardial ischemia and drug treatment.